OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trem2 deletion enhances tau dispersion and pathology through microglia exosomes
Bing Zhu, Yan Liu, Spring Hwang, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation
Yijun Chen, Yang Yu
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 146

TREM2: Potential therapeutic targeting of microglia for Alzheimer's disease
Yueran Li, Huifang Xu, Huifang Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115218-115218
Open Access | Times Cited: 46

Cellular and pathological functions of tau
C Bravo, Sarah Naguib, Li Gan
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 11, pp. 845-864
Closed Access | Times Cited: 34

Immune Activation in Alzheimer Disease
Arnaud Mary, Renzo Mancuso, Michael T. Heneka
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 585-613
Closed Access | Times Cited: 19

Targeting tau in Alzheimer's disease: from mechanisms to clinical therapy
Jinwang Ye, Hua-Li Wan, Sihua Chen, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 7, pp. 1489-1498
Open Access | Times Cited: 22

Microglia and TREM2
Jennifer M. Pocock, Foteini Vasilopoulou, Elina Svensson, et al.
Neuropharmacology (2024) Vol. 257, pp. 110020-110020
Closed Access | Times Cited: 11

Unveiling the Complex Role of Exosomes in Alzheimer’s Disease
Mingyue Sun, Zhuoyou Chen
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3921-3948
Open Access | Times Cited: 11

Smart Nanoscale Extracellular Vesicles in the Brain: Unveiling their Biology, Diagnostic Potential, and Therapeutic Applications
Akanksha Onkar, Fatima Khan, Anshika Goenka, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 6, pp. 6709-6742
Closed Access | Times Cited: 10

TREM2 in Alzheimer's disease: Structure, function, therapeutic prospects, and activation challenges
Emilia Zgórzyńska
Molecular and Cellular Neuroscience (2024) Vol. 128, pp. 103917-103917
Closed Access | Times Cited: 9

Loss of TMEM106B exacerbates Tau pathology and neurodegeneration in PS19 mice
Tuancheng Feng, Huan Du, Cha Yang, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 9

Exosomes: potential targets for the diagnosis and treatment of neuropsychiatric disorders
Haorao Li, Yanling Yuan, Qinglian Xie, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8

Neutral or detrimental effects of TREM2 agonist antibodies in preclinical models of Alzheimer's Disease and Multiple Sclerosis
Ainhoa Etxeberría, Yun‐An A. Shen, Stephen Vito, et al.
Journal of Neuroscience (2024) Vol. 44, Iss. 29, pp. e2347232024-e2347232024
Closed Access | Times Cited: 8

Advancements in extracellular vesicles biomanufacturing: a comprehensive overview of large-scale production and clinical research
Ziqian Li, Junyu Yan, Xiang Li, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access | Times Cited: 1

The emerging double-edged sword role of exosomes in Alzheimer’s disease
Tao Liang, Zubo Wu, Junjun Li, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 18

The role of TREM2 in Alzheimer’s disease: from the perspective of Tau
Wendi Huang, Juan Huang, Nanqu Huang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 18

Alzheimer’s genes in microglia: a risk worth investigating
Ari Sudwarts, Gopal Thinakaran
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 16

Novel avenues of tau research
Claire E. Sexton, Gal Bitan, Kathryn R. Bowles, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 3, pp. 2240-2261
Open Access | Times Cited: 6

Intranasal Administration of Umbilical Cord Mesenchymal Stem Cell Exosomes Alleviates Parkinson's Disease
Weixiao Huang, Tao Zhang, Xiaodi Li, et al.
Neuroscience (2024) Vol. 549, pp. 1-12
Open Access | Times Cited: 6

Galectin-3 aggravates microglial activation and tau transmission in tauopathy
Jian Jing Siew, Hui-Mei Chen, Feng‐Lan Chiu, et al.
Journal of Clinical Investigation (2023) Vol. 134, Iss. 2
Open Access | Times Cited: 13

Data‐driven decomposition and staging of flortaucipir uptake in Alzheimer's disease
Tom Earnest, Abdalla Bani, Sung Min Ha, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 6, pp. 4002-4019
Open Access | Times Cited: 5

Exosome-based drug delivery systems for enhanced neurological therapeutics
Safa A Vahab, K V Vyshma, Vrinda S Kumar
Drug Delivery and Translational Research (2024) Vol. 15, Iss. 4, pp. 1121-1138
Closed Access | Times Cited: 5

Complexity of Sex Differences and Their Impact on Alzheimer’s Disease
Marion Kadlecova, Kristine Freude, Henriette Haukedal
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1261-1261
Open Access | Times Cited: 12

The unique neuropathological vulnerability of the human brain to aging
Isidró Ferrer
Ageing Research Reviews (2023) Vol. 87, pp. 101916-101916
Open Access | Times Cited: 11

The dichotomous activities of microglia: A potential driver for phenotypic heterogeneity in Alzheimer’s disease
Anna Pumo, Samuel Legeay
Brain Research (2024) Vol. 1832, pp. 148817-148817
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top